Sign in
Enrolling by invitationNo phase

Following health outcomes of adults with chronic liver disease and cirrhosis

Reviews how adults with chronic liver disease do over time.

Key facts

Who runs it
Target PharmaSolutions, Inc.
Where
Charlotte, Chicago, Dallas, Houston, Los Angeles, New York, Philadelphia, Redwood City, and Washington D.C., United StatesSee the 10 sites
Trial code
Registry title
An Observational Study of Patients With Chronic Liver Disease
Status
Enrolling by invitation
People taking part
500,000 people, planned
Started
19 Feb 2024
Expected to end
31 Dec 2037
Type of study
Observational, 2 groups
Treatments tested
  • Observational
Record updated
3 March 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with chronic liver disease or cirrhosis (scarring of the liver). It only observes and records how patients do over time.

Age
18 years and older
Sex
All sexes
Disease stage
A diagnosis of chronic liver disease or cirrhosis recorded in the electronic health record. Some people are also invited to fill in surveys about their health.
Earlier treatment
For the survey group: people must be diagnosed and cared for because of chronic liver disease or cirrhosis.

Main reasons for not taking part

  • No visit recorded in the electronic health record for more than 3 years
  • Removed from the study at the request of the sponsor or the site
  • Survey group: not completing the surveys within 24 weeks of the first invitation
  • Survey group: more than 24 months without completing surveys after the first surveys
  • Survey group: wanting to stop giving consent for the surveys

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • Disease Cohort
  • •Adult* patients at the time of enrollment with a diagnosis of CLD/cirrhosis by ICD-10 code in the EHR interface
  • Engaged Cohort
  • Adult* patients diagnosed and managed for CLD/cirrhosis invited to participate
  • Ability to provide written informed consent

Who cannot take part

  • Disease Cohort
  • Failure to complete PROs within 24 weeks of initial invitation
  • Additionally, the criteria detailed for Disease Cohort apply to the Engaged Cohort
  • No EHR interface encounter > 3 years; Engaged Cohort
  • Death
  • Manual removal (sponsor or site request)
  • Patient expressed desire to withdraw consent to complete PROs
  • Greater than 24 months lapse of survey completion after baseline surveys completed

Where in United States

  • Atrium Health Center for Liver Disease and TransplantCharlotte, United StatesEnrolling by invitation
  • Rush University Medical CenterChicago, United StatesEnrolling by invitation
  • Baylor Scott & White Research InstituteDallas, United StatesEnrolling by invitation
  • Baylor College of MedicineHouston, United StatesEnrolling by invitation
  • Keck School of Medicine of USCLos Angeles, United StatesEnrolling by invitation
  • Columbia University Irving Medical Center/New York Presbyterian HospitalNew York, United StatesEnrolling by invitation
  • Temple University Lewis Katz School of MedicinePhiladelphia, United StatesEnrolling by invitation
  • University of PennsylvaniaPhiladelphia, United StatesEnrolling by invitation
  • Stanford MedicineRedwood City, United StatesEnrolling by invitation
  • Georgetown Medstar Transplant InstituteWashington D.C., United StatesEnrolling by invitation

About the trial

What the trial wants to find out

TARGET-Liver Disease (TARGET-LD) is an observational research study to conduct a comprehensive review of outcomes for patients with chronic liver disease (CLD).

The 2 groups in the trial

  • Disease Cohort

    Treatment: Observational

  • Engaged Cohort

    Treatment: Observational

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
An Observational Study of Patients With Chronic Liver Disease
Plain-language title
Following health outcomes of adults with chronic liver disease and cirrhosisGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
3 March 2026